Eisenberger MA - Search Results

1

Clinical practice. Localized prostate cancer.

Walsh PC, DeWeese TL, Eisenberger MA. Walsh PC, et al. Among authors: eisenberger ma. N Engl J Med. 2007 Dec 27;357(26):2696-705. doi: 10.1056/NEJMcp0706784. N Engl J Med. 2007. PMID: 18160689 Review. No abstract available.

2

Leuprolide with and without flutamide in advanced prostate cancer.

Crawford ED, Blumenstein BA, Goodman PJ, Davis MA, Eisenberger MA, McLeod DG, Spaulding JT, Benson R, Dorr FA. Crawford ED, et al. Among authors: eisenberger ma. Cancer. 1990 Sep 1;66(5 Suppl):1039-44. doi: 10.1002/cncr.1990.66.s5.1039. Cancer. 1990. PMID: 2118417 Clinical Trial.

3

Chemotherapy for endocrine resistant cancer of the prostate.

Eisenberger MA. Eisenberger MA. Prog Clin Biol Res. 1990;359:155-64; discussion 177-80. Prog Clin Biol Res. 1990. PMID: 2284289 Review. No abstract available.

4

Chemotherapy for prostate carcinoma.

Eisenberger MA. Eisenberger MA. NCI Monogr. 1988;(7):151-63. NCI Monogr. 1988. PMID: 3050534 Review.

5

Chemotherapy for prostatic carcinoma.

Eisenberger MA, Abrams JS. Eisenberger MA, et al. Semin Urol. 1988 Nov;6(4):303-10. Semin Urol. 1988. PMID: 3068768 Review. No abstract available.

6

Prostate Cancer Awareness Week, 1992: a summary of key findings.

DeAntoni E, Crawford ED, Stone NN, Blum DS, Berger ER, Eisenberger MA, Gambert SR, Staggers F. DeAntoni E, et al. Among authors: eisenberger ma. Clin Invest Med. 1993 Dec;16(6):448-57. Clin Invest Med. 1993. PMID: 7516833 Review.

7

Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate.

Nelson JB, Hedican SP, George DJ, Reddi AH, Piantadosi S, Eisenberger MA, Simons JW. Nelson JB, et al. Among authors: eisenberger ma. Nat Med. 1995 Sep;1(9):944-9. doi: 10.1038/nm0995-944. Nat Med. 1995. PMID: 7585222

8

Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer.

Eisenberger MA, Sinibaldi VJ, Reyno LM, Sridhara R, Jodrell DI, Zuhowski EG, Tkaczuk KH, Lowitt MH, Hemady RK, Jacobs SC, et al. Eisenberger MA, et al. J Clin Oncol. 1995 Sep;13(9):2174-86. doi: 10.1200/JCO.1995.13.9.2174. J Clin Oncol. 1995. PMID: 7666076 Clinical Trial.

9

Interleukin-6: a candidate mediator of human prostate cancer morbidity.

Twillie DA, Eisenberger MA, Carducci MA, Hseih WS, Kim WY, Simons JW. Twillie DA, et al. Among authors: eisenberger ma. Urology. 1995 Mar;45(3):542-9. doi: 10.1016/S0090-4295(99)80034-X. Urology. 1995. PMID: 7879350

10

Prognostic factors in stage D2 prostate cancer; important implications for future trials: results of a cooperative intergroup study (INT.0036). The National Cancer Institute Intergroup Study #0036.

Eisenberger MA, Crawford ED, Wolf M, Blumenstein B, McLeod DG, Benson R, Dorr FA, Benson M, Spaulding JT. Eisenberger MA, et al. Semin Oncol. 1994 Oct;21(5):613-9. Semin Oncol. 1994. PMID: 7939752 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results